Stay updated with breaking news from Brigham Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price hoisted by stock analysts at Oppenheimer from $43.00 to $45.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price suggests a potential upside of 20.29% from the […]
Revolution Medicines (NASDAQ:RVMD – Get Free Report) was upgraded by equities research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a note issued to investors on Wednesday, MarketBeat reports. The brokerage presently has a $48.00 target price on the stock, up from their prior target price of $36.00. Raymond James’ […]
Cantor Fitzgerald initiated coverage on shares of Tango Therapeutics (NASDAQ:TNGX – Free Report) in a research note issued to investors on Thursday morning, MarketBeat Ratings reports. The firm issued an overweight rating on the stock. TNGX has been the subject of a number of other research reports. HC Wainwright boosted their price objective on shares […]
The Federal Emergency Management Agency on Wednesday announced nearly $100 million will be awarded to Massachusetts to reimburse the state and local hospitals for COVID staffing costs during the pandemic.
Mass General Brigham Inc decreased its holdings in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 26.8% in the second quarter, Holdings Channel reports. The firm owned 120,617 shares of the company’s stock after selling 44,185 shares during the quarter. iShares Core S&P 500 ETF comprises about 48.9% of Mass General […]